SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Nutraceutical

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2109028

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2109028

Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region - Global Forecast to 2031

PUBLISHED:
PAGES: 267 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The Vitamin K2 market is projected to reach USD 339.9 million by 2031 from USD 179.0 million in 2026, at a CAGR of 13.7% from 2026 to 2031. This growth is propelled by increasing awareness of consumers regarding bone and cardiovascular health, increasing demand for preventive healthcare, and rising adoption of dietary supplements and functional nutrition products. Consumers are increasingly prioritizing long-term health and wellness, resulting in higher demand for Vitamin K2 ingredients that support calcium metabolism, bone mineralization, and cardiovascular health.

Scope of the Report
Years Considered for the Study2022-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD MN), Volume (KT)
Segmentsby Application, Product Type, Application Form, Source, Function, and Region
Regions coveredNorth America, Europe, APAC, RoW

In addition, the growing preference for scientifically validated, clean-label, and naturally derived ingredients is encouraging the adoption of fermentation-based Vitamin K2 across dietary supplements, functional foods and beverages, and pharmaceutical applications. The expanding aging population, increasing incidence of osteoporosis and cardiovascular disorders, and rising healthcare expenditure are further supporting market expansion across developed and emerging economies.

Vitamin K2 Market - IMG1

Manufacturers are continuously investing in product innovation and advanced production technologies to improve the purity, stability, and bioavailability of Vitamin K2 ingredients. There is a growing focus on developing high-quality MK7 and MK4 formulations through natural fermentation, chemical synthesis, and biotechnological fermentation technologies to meet evolving customer and regulatory requirements. Advancements in purifying processes, microencapsulation technologies, and formulation solutions are enabling manufacturers to enhance ingredient stability and application diversity across multiple product formats. Additionally, increasing scientific research, expanding regulatory approvals, and growing incorporation of Vitamin K2 into personalized nutrition solutions and functional health products are creating new growth opportunities for market participants. However, challenges such as stringent regulatory requirements, limited consumer awareness in developing regions, raw material and production costs, and increasing competition among manufacturers may restrain market growth.

"By product type, the MK-7 segment is expected to be the dominant segment in the market."

By product type, the MK-7 segment is projected to be the dominant segment in the market. Vitamin K2 MK7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification. Its role in activating key proteins like osteocalcin and Matrix Gla Protein (MGP) underscores its efficacy in supporting skeletal integrity and cardiovascular flexibility. As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.

"The pharmaceuticals segment in the Vitamin K2 market is projected to have significant growth during the forecast period."

Vitamin K2 has shown various potential benefits in pharmaceutical applications, which are expected to drive demand for this ingredient in the industry. However, there is a stringent regulatory structure for the usage of Vitamin K2 in pharmaceutical applications across regions. Multiple primary industry experts from various Vitamin K2 manufacturers agreed that the usage of Vitamin K2 in pharmaceutical applications is limited to Asia Pacific; within this region, although some countries manufacture Vitamin K2 for pharmaceutical applications, the consumption is mainly observed in China and Japan. Thus, recent government insights, along with ongoing research and clinical trials, support the potential benefits of Vitamin K2 in pharmaceutical applications.

"Asia Pacific is projected to be the fastest-growing region in the global Vitamin K2 market during the forecast period."

The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region's rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.

Additionally, the robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Vitamin K2 market.

  • By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
  • By Designation: CXOs - 25%, Managers - 35%, Others - 40%

Prominent companies in the market include Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), and others.

Research Coverage

This research report categorizes the Vitamin K2 market by product type (MK4 and MK7), application form (capsules and tablets, powder and crystalline, and liquids), source (natural and synthetic), application (pharmaceuticals, functional foods and beverages, and health supplements), function (bone and cardiovascular health, blood health and clotting, anti-inflammatory and immunity, and other functions), processing technology (natural fermentation, chemical synthesis, biotechnological fermentation, and other production technologies) and region (North America, Europe, Asia Pacific, and Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Vitamin K2 industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Vitamin K2 market. This report provides a competitive analysis of emerging startups in the Vitamin K2 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Vitamin K2 and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (rising health consciousness among consumers), restraints (inconsistency in regulatory norms), opportunities (growing demand for natural and plant-based ingredients), and challenges (lack of consumer awareness regarding specific health benefits of Vitamin k2) influencing the growth of the Vitamin K2 market
  • Product Development/Innovation: Detailed insights into research & development activities and product launches in the Vitamin K2 market
  • Market Development: Comprehensive information about lucrative market analysis of Vitamin K2 across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Vitamin K2 market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Shandong Richen Nutritional Technology Co., Ltd. (China), Menadiona S.L. (Spain), GF Fermentech Co., Ltd. (South Korea), Angel Yeast Co., Ltd. (China), GeneFerm Biotechnology Co., Ltd. (Taiwan), Nakoda Chemicals Ltd. (India), Haihang Industry Co., Ltd. (China), Chemicea Limited (India), and Kyowa Hakko U.S.A., Inc. (US) in the Vitamin K2 market
Show more
Product Code: FB 9049

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE AND SEGMENTATION
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNIT CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN VITAMIN K2 MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET
  • 3.2 VITAMIN K2 MARKET, BY APPLICATION FORM AND REGION
  • 3.3 VITAMIN K2 MARKET, BY SOURCE
  • 3.4 VITAMIN K2 MARKET, BY APPLICATION
  • 3.5 VITAMIN K2 MARKET, BY PRODUCT TYPE
  • 3.6 VITAMIN K2 MARKET, BY APPLICATION FORM
  • 3.7 VITAMIN K2 MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising health consciousness among consumers
      • 4.2.1.2 Increasing research and development activities
      • 4.2.1.3 Growing aging population and rising prevalence of bone & cardiovascular disorders
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Inconsistency in regulatory norms
      • 4.2.2.2 Price volatility of raw materials
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing demand for natural and plant-based ingredients
      • 4.2.3.2 Rising need for personalized nutrition and customized products
      • 4.2.3.3 Untapped applications
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Lack of consumer awareness regarding specific health benefits
      • 4.2.4.2 High research and development costs
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN VITAMIN K2 MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMICS OUTLOOK
    • 5.2.1 INTRODUCTION
      • 5.2.1.1 Macroeconomic indicators
        • 5.2.1.1.1 Rising world GDP and population
        • 5.2.1.1.2 Rise in health concerns and disease incidences
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH AND DEVELOPMENT
    • 5.3.2 RAW MATERIAL SOURCING
    • 5.3.3 PRODUCTION AND PROCESSING
    • 5.3.4 QUALITY ASSURANCE
    • 5.3.5 MARKETING, DISTRIBUTION, & SALES
    • 5.3.6 END USERS
  • 5.4 ECOSYSTEM ANALYSIS
    • 5.4.1 DEMAND SIDE
    • 5.4.2 SUPPLY SIDE
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INTRODUCTION
    • 5.5.2 AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE, 2022-2025 (USD/TONS)
    • 5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TONS)
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
    • 5.6.2 EXPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 GNOSIS BY LESAFFRE - LAUNCH OF MENAQ7 OLIVE OIL
    • 5.10.2 BALCHEM CORP.- ACQUISITION OF KAPPA BIOSCIENCE
  • 5.11 IMPACT OF 2025 US TARIFF - VITAMIN K2 MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 PRICE IMPACT ANALYSIS
    • 5.11.3 IMPACT ON COUNTRIES/REGIONS
      • 5.11.3.1 US
      • 5.11.3.2 Europe
      • 5.11.3.3 Asia Pacific
    • 5.11.4 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Fermentation technology
      • 6.1.1.2 Bioreactor process control technology
    • 6.1.2 COMPLEMENTARY ANALYSIS
      • 6.1.2.1 Encapsulation technology
      • 6.1.2.2 Spray drying technology
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Synthetic biology
      • 6.1.3.2 Continuous manufacturing technology
    • 6.1.4 TECHNOLOGY/PRODUCT ROADMAP
      • 6.1.4.1 Short-term | Process optimization & high-purity ingredient expansion
      • 6.1.4.2 Mid-term | Personalized nutrition & sustainable bioprocessing
      • 6.1.4.3 Long-term | Synthetic biology & next-generation precision health
  • 6.2 PATENT ANALYSIS
  • 6.3 FUTURE APPLICATIONS
    • 6.3.1 AI-DRIVEN PRECISION FERMENTATION: OPTIMIZING VITAMIN K2 PRODUCTION
    • 6.3.2 SYNTHETIC BIOLOGY: ENGINEERING HIGH-PERFORMANCE MICROBIAL STRAINS
    • 6.3.3 PRECISION NUTRITION & PERSONALIZED SUPPLEMENTATION: ADVANCING PREVENTIVE HEALTHCARE
    • 6.3.4 ADVANCED DELIVERY SYSTEMS & SMART FORMULATIONS: IMPROVING BIOAVAILABILITY
    • 6.3.5 DIGITAL MANUFACTURING & SMART QUALITY CONTROL: ENHANCING PRODUCTION EFFICIENCY
  • 6.4 IMPACT OF GENERATIVE AI ON VITAMIN K2 MARKET
    • 6.4.1 INTRODUCTION
    • 6.4.2 CASE STUDIES OF AI IMPLEMENTATION IN VITAMIN K2 MARKET
    • 6.4.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.4.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VITAMIN K2 MARKET
  • 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
    • 7.1.3 LABELING REQUIREMENTS AND CLAIMS
    • 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
      • 7.1.4.1 Enhanced ingredient traceability and supply chain transparency
      • 7.1.4.2 Greater harmonization of global regulatory standards
      • 7.1.4.3 Stricter sustainability and responsible manufacturing requirements
      • 7.1.4.4 Digital compliance, smart manufacturing, and quality management
      • 7.1.4.5 Expanded regulation of novel production technologies and health claims
      • 7.1.4.6 Strengthened labeling and consumer transparency requirements
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 SUSTAINABLE SOURCING
    • 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
    • 7.2.3 CIRCULAR ECONOMY APPROACHES
  • 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • 8.5 MARKET PROFITABILITY
  • 8.6 REVENUE POTENTIAL
    • 8.6.1 COST DYNAMICS
    • 8.6.2 MARGIN OPPORTUNITIES, BY PRODUCT TYPE

9 VITAMIN K2 MARKET, BY FUNCTION

  • 9.1 INTRODUCTION
  • 9.2 BONE AND CARDIOVASCULAR HEALTH
    • 9.2.1 RISING PREVALENCE OF OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS TO DRIVE VITAMIN K2 ADOPTION IN BONE AND CARDIOVASCULAR HEALTH FORMULATIONS
  • 9.3 BLOOD HEALTH AND CLOTTING
    • 9.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
  • 9.4 ANTI-INFLAMMATORY AND IMMUNITY
    • 9.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
  • 9.5 OTHER FUNCTIONS

10 VITAMIN K2 MARKET, BY PRODUCTION TECHNOLOGY

  • 10.1 INTRODUCTION
  • 10.2 NATURAL FERMENTATION
    • 10.2.1 PREFERRED PRODUCTION TECHNOLOGY FOR PREMIUM VITAMIN K2 (MK-7) DUE TO SUPERIOR BIOAVAILABILITY, NATURAL ORIGIN, AND STRONG CONSUMER ACCEPTANCE
  • 10.3 CHEMICAL SYNTHESIS
    • 10.3.1 COST-EFFECTIVE PRODUCTION AND HIGH MANUFACTURING SCALABILITY, PARTICULARLY FOR VITAMIN K2 (MK-4)
  • 10.4 BIOTECHNOLOGICAL FERMENTATION
    • 10.4.1 ENHANCES PRODUCTION EFFICIENCY THROUGH ADVANCED MICROBIAL ENGINEERING AND PRECISION BIOPROCESS TECHNOLOGIES
  • 10.5 OTHER PRODUCTION TECHNOLOGIES

11 VITAMIN K2 MARKET, BY PRODUCT TYPE

  • 11.1 INTRODUCTION
  • 11.2 MK7
    • 11.2.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
  • 11.3 MK4
    • 11.3.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET

12 VITAMIN K2 MARKET, BY SOURCE

  • 12.1 INTRODUCTION
  • 12.2 NATURAL
    • 12.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
  • 12.3 SYNTHETIC
    • 12.3.1 LOW PRODUCTION COST TO DRIVE MARKET

13 VITAMIN K2 MARKET, BY APPLICATION

  • 13.1 INTRODUCTION
  • 13.2 HEALTH SUPPLEMENTS
    • 13.2.1 GROWING ADOPTION OF PREVENTIVE NUTRITION AND CLINICALLY SUPPORTED DIETARY SUPPLEMENTS TO DRIVE SEGMENT
  • 13.3 FUNCTIONAL FOOD & BEVERAGES
    • 13.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
  • 13.4 PHARMACEUTICALS
    • 13.4.1 RISING INVESTMENTS FOR DEVELOPING NEW FORMULATIONS TO DRIVE MARKET

14 VITAMIN K2 MARKET, BY APPLICATION FORM

  • 14.1 INTRODUCTION
  • 14.2 CAPSULES & TABLETS
    • 14.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
  • 14.3 POWDER & CRYSTALLINE
    • 14.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
  • 14.4 LIQUIDS
    • 14.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH

15 VITAMIN K2 MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 US
      • 15.2.1.1 Growing awareness about preventive health measures to drive market
    • 15.2.2 CANADA
      • 15.2.2.1 Increasing focus on preventive healthcare and natural products to propel market
    • 15.2.3 MEXICO
      • 15.2.3.1 High prevalence of chronic lifestyle diseases to drive market
  • 15.3 EUROPE
    • 15.3.1 GERMANY
      • 15.3.1.1 Rising focus on proactive healthcare to drive market
    • 15.3.2 FRANCE
      • 15.3.2.1 Investments in R&D and product innovation to boost market growth
    • 15.3.3 UK
      • 15.3.3.1 Rapidly aging population to propel market growth
    • 15.3.4 ITALY
      • 15.3.4.1 Aging population and preventive healthcare trends to support vitamin K2 adoption
    • 15.3.5 SPAIN
      • 15.3.5.1 Growing consumer interest in health supplements to drive demand
    • 15.3.6 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 CHINA
      • 15.4.1.1 Surging use of digital media to disseminate healthcare information to propel market
    • 15.4.2 JAPAN
      • 15.4.2.1 Consumer preferences for natural healthcare solutions to boost market growth
    • 15.4.3 INDIA
      • 15.4.3.1 Strategic market penetration initiatives by various companies to drive market
    • 15.4.4 AUSTRALIA AND NEW ZEALAND
      • 15.4.4.1 Changing consumer preferences and increasing health consciousness to drive demand
    • 15.4.5 REST OF ASIA PACIFIC
  • 15.5 REST OF THE WORLD
    • 15.5.1 SOUTH AMERICA
      • 15.5.1.1 Rising preventive healthcare awareness and expanding nutraceutical industry to support market growth
    • 15.5.2 MIDDLE EAST & AFRICA
      • 15.5.2.1 Rising healthcare investments and growing preventive nutrition awareness to support market growth

16 COMPETITIVE LANDSCAPE

  • 16.1 OVERVIEW
  • 16.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 2021-2026
  • 16.3 REVENUE ANALYSIS, 2023-2025
  • 16.4 MARKET SHARE ANALYSIS, 2025
    • 16.4.1 BRAND COMPARISON
    • 16.4.2 NOVONESIS GROUP (MENAQUINGOLD)
    • 16.4.3 GNOSIS BY LESAFFRE (MENAQ7)
    • 16.4.4 BALCHEM CORP. (K2VITAL)
    • 16.4.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD. (ESSEK2)
    • 16.4.6 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (MENNATO)
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Region footprint
      • 16.5.5.3 Application footprint
      • 16.5.5.4 Product type footprint
  • 16.6 COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 RESPONSIVE COMPANIES
    • 16.6.3 DYNAMIC COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: DISTRIBUTORS/SUPPLIERS, 2025
      • 16.6.5.1 Detailed list of key distributors/suppliers
      • 16.6.5.2 Competitive benchmarking of key distributors/suppliers
  • 16.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 16.7.1 COMPANY VALUATION
    • 16.7.2 EV/EBITDA
  • 16.8 COMPETITIVE SCENARIO
    • 16.8.1 PRODUCT LAUNCHES/DEVELOPMENTS
    • 16.8.2 DEALS
    • 16.8.3 EXPANSIONS
    • 16.8.4 OTHER DEVELOPMENTS

17 COMPANY PROFILES

  • 17.1 KEY PLAYERS (MANUFACTURERS)
    • 17.1.1 GNOSIS BY LESAFFRE
      • 17.1.1.1 Business overview
      • 17.1.1.2 Products/Solutions/Services offered
      • 17.1.1.3 Recent developments
        • 17.1.1.3.1 Product launches/developments
        • 17.1.1.3.2 Deals
      • 17.1.1.4 MnM view
        • 17.1.1.4.1 Right to win
        • 17.1.1.4.2 Strategic choices
        • 17.1.1.4.3 Weaknesses and competitive threats
    • 17.1.2 BALCHEM CORP.
      • 17.1.2.1 Business overview
      • 17.1.2.2 Products/Solutions/Services offered
      • 17.1.2.3 Recent developments
        • 17.1.2.3.1 Product launches/developments
        • 17.1.2.3.2 Deals
        • 17.1.2.3.3 Expansions
      • 17.1.2.4 MnM view
        • 17.1.2.4.1 Right to win
        • 17.1.2.4.2 Strategic choices
        • 17.1.2.4.3 Weaknesses and competitive threats
    • 17.1.3 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.)
      • 17.1.3.1 Business overview
      • 17.1.3.2 Products/Solutions/Services offered
      • 17.1.3.3 Recent developments
        • 17.1.3.3.1 Product launches/developments
        • 17.1.3.3.2 Deals
      • 17.1.3.4 MnM view
        • 17.1.3.4.1 Right to win
        • 17.1.3.4.2 Strategic choices
        • 17.1.3.4.3 Weaknesses and competitive threats
    • 17.1.4 NOVONESIS GROUP
      • 17.1.4.1 Business overview
      • 17.1.4.2 Products/Solutions/Services offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Deals
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Right to win
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses and competitive threats
    • 17.1.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.
      • 17.1.5.1 Business overview
      • 17.1.5.2 Products/Solutions/Services offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Other developments
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Right to win
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses and competitive threats
    • 17.1.6 VESTA NUTRA
      • 17.1.6.1 Business overview
      • 17.1.6.2 Products/Solutions/Services offered
      • 17.1.6.3 Recent developments
      • 17.1.6.4 MnM view
    • 17.1.7 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
      • 17.1.7.1 Business overview
      • 17.1.7.2 Products/Solutions/Services offered
      • 17.1.7.3 Recent developments
        • 17.1.7.3.1 Product launches/developments
        • 17.1.7.3.2 Other developments
      • 17.1.7.4 MnM view
    • 17.1.8 MENADIONA
      • 17.1.8.1 Business overview
      • 17.1.8.2 Products/Solutions/Services offered
      • 17.1.8.3 Recent developments
        • 17.1.8.3.1 Product launches/developments
      • 17.1.8.4 MnM view
    • 17.1.9 GF FERMENTECH CO., LTD.
      • 17.1.9.1 Business overview
      • 17.1.9.2 Products/Solutions/Services offered
      • 17.1.9.3 Recent developments
        • 17.1.9.3.1 Product launches/developments
        • 17.1.9.3.2 Deals
      • 17.1.9.4 MnM view
    • 17.1.10 ANGELYEAST CO., LTD.
      • 17.1.10.1 Business overview
      • 17.1.10.2 Products/Solutions/Services offered
      • 17.1.10.3 Recent developments
        • 17.1.10.3.1 Expansions
      • 17.1.10.4 MnM view
    • 17.1.11 GENEFERM BIOTECHNOLOGY CO., LTD.
      • 17.1.11.1 Business overview
      • 17.1.11.2 Products/Solutions/Services offered
      • 17.1.11.3 Recent developments
        • 17.1.11.3.1 Expansions
      • 17.1.11.4 MnM view
    • 17.1.12 NAKODA CHEMICALS LTD.
      • 17.1.12.1 Business overview
      • 17.1.12.2 Products/Solutions/Services offered
      • 17.1.12.3 Recent developments
      • 17.1.12.4 MnM view
    • 17.1.13 HAIHANG INDUSTRY CO., LTD.
      • 17.1.13.1 Business overview
      • 17.1.13.2 Products/Solutions/Services offered
      • 17.1.13.3 Recent developments
      • 17.1.13.4 MnM view
    • 17.1.14 CHEMICEA LIMITED
      • 17.1.14.1 Business overview
      • 17.1.14.2 Products/Solutions/Services offered
      • 17.1.14.3 Recent developments
      • 17.1.14.4 MnM view
    • 17.1.15 KYOWA HAKKO U.S.A., INC.
      • 17.1.15.1 Business overview
      • 17.1.15.2 Products/Solutions/Services offered
      • 17.1.15.3 Recent developments
      • 17.1.15.4 MnM view
  • 17.2 DISTRIBUTORS/SUPPLIERS
    • 17.2.1 SEEBIO BIOTECH (SHANGHAI) CO., LTD.
    • 17.2.2 MAGNESIA GMBH
    • 17.2.3 FALCON TRADING INTERNATIONAL
    • 17.2.4 ABCO INDIA
    • 17.2.5 ATLANTIC CHEMICALS TRADING GMBH

18 RESEARCH METHODOLOGY

  • 18.1 RESEARCH DATA
    • 18.1.1 SECONDARY DATA
      • 18.1.1.1 Key data from secondary sources
    • 18.1.2 PRIMARY DATA
      • 18.1.2.1 Key data from primary sources
      • 18.1.2.2 Breakdown of primary profiles
      • 18.1.2.3 Key insights from industry experts
  • 18.2 MARKET SIZE ESTIMATION
    • 18.2.1 TOP-DOWN APPROACH
    • 18.2.2 SUPPLY-SIDE ANALYSIS
    • 18.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
  • 18.3 DATA TRIANGULATION AND MARKET BREAKUP
  • 18.4 RESEARCH ASSUMPTIONS
  • 18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

19 ADJACENT AND RELATED MARKETS

  • 19.1 INTRODUCTION
  • 19.2 RESEARCH LIMITATIONS
  • 19.3 DIETARY SUPPLEMENTS MARKET
    • 19.3.1 MARKET DEFINITION
    • 19.3.2 MARKET OVERVIEW
  • 19.4 VITAMINS MARKET
    • 19.4.1 MARKET DEFINITION
    • 19.4.2 MARKET OVERVIEW

20 APPENDIX

  • 20.1 DISCUSSION GUIDE
  • 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 20.3 CUSTOMIZATION OPTIONS
  • 20.4 RELATED REPORTS
  • 20.5 AUTHOR DETAILS
Show more
Product Code: FB 9049

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 USD EXCHANGE RATES, 2022-2025
  • TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON VITAMIN K2 MARKET
  • TABLE 4 VITAMIN K2 MARKET: SUPPLY SIDE (ECOSYSTEM)
  • TABLE 5 AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE, 2022-2025 (USD/TONS)
  • TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TONS)
  • TABLE 7 TOP IMPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021-2025 (USD MILLION)
  • TABLE 8 TOP EXPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021-2025 (USD MILLION)
  • TABLE 9 VITAMIN K2 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 10 PATENTS PERTAINING TO VITAMIN K2 MARKET, 2024-2026
  • TABLE 11 VITAMIN K2 MARKET: CASE STUDIES RELATED TO GENERATIVE AI IMPLEMENTATION
  • TABLE 12 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 INTERNATIONAL: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 GLOBAL INDUSTRY STANDARDS IN VITAMIN K2 MARKET
  • TABLE 18 LABELING REQUIREMENTS AND CLAIMS IN VITAMIN K2 MARKET
  • TABLE 19 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN VITAMIN K2 MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
  • TABLE 21 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • TABLE 22 UNMET NEEDS IN VITAMIN K2 MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • TABLE 23 COST DYNAMICS IN VITAMIN K2 MARKET
  • TABLE 24 MARGIN OPPORTUNITIES IN VITAMIN K2 MARKET, BY PRODUCT TYPE
  • TABLE 25 PRODUCTION TECHNOLOGY APPLIED BY KEY PLAYERS
  • TABLE 26 PRODUCT TYPE: OVERVIEW
  • TABLE 27 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 28 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 29 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (TON)
  • TABLE 30 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (TON)
  • TABLE 31 MK7: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 32 MK7: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 33 MK7: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 34 MK7: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 35 MK7: VITAMIN K2 MARKET, BY REGION, 2022-2025 (TON)
  • TABLE 36 MK7: VITAMIN K2 MARKET, BY REGION, 2026-2031 (TON)
  • TABLE 37 MK4: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 38 MK4: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 39 MK4: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 40 MK4: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 41 MK4: VITAMIN K2 MARKET, BY REGION, 2022-2025 (TON)
  • TABLE 42 MK4: VITAMIN K2 MARKET, BY REGION, 2026-2031 (TON)
  • TABLE 43 VITAMIN K2 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 44 VITAMIN K2 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 45 NATURAL: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 46 NATURAL: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 47 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 48 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 49 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 50 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 51 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 52 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 53 HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 54 HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 55 HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 56 HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 57 FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 58 FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 59 FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 60 FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 61 FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 62 FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 63 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 64 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 65 PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 66 PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 67 PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 68 PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 69 VITAMIN K2 MARKET, BY APPLICATION FORM, 2022-2025 (USD MILLION)
  • TABLE 70 VITAMIN K2 MARKET, BY APPLICATION FORM, 2026-2031 (USD MILLION)
  • TABLE 71 CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 72 CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 73 POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 74 POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 75 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 76 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 77 VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 78 VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 79 VITAMIN K2 MARKET, BY REGION, 2022-2025 (TON)
  • TABLE 80 VITAMIN K2 MARKET, BY REGION, 2026-2031 (TON)
  • TABLE 81 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 82 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 83 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (TON)
  • TABLE 84 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (TON)
  • TABLE 85 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 86 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (TON)
  • TABLE 88 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (TON)
  • TABLE 89 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022-2025 (USD MILLION)
  • TABLE 90 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 92 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 94 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 96 NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 98 NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 99 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 100 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 101 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 102 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 103 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 104 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 105 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 106 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 107 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (TON)
  • TABLE 108 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (TON)
  • TABLE 109 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 110 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 111 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (TON)
  • TABLE 112 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (TON)
  • TABLE 113 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022-2025 (USD MILLION)
  • TABLE 114 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026-2031 (USD MILLION)
  • TABLE 115 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 116 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 117 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 118 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 119 EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 120 EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 121 EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 122 EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 123 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 124 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 125 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 126 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 127 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 128 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 129 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 130 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 131 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 132 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 133 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 134 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022-2025 (TON)
  • TABLE 138 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026-2031 (TON)
  • TABLE 139 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (TON)
  • TABLE 142 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (TON)
  • TABLE 143 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022-2025 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026-2031 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 153 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 154 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 155 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 156 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 157 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 158 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 159 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 160 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 161 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 162 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 163 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 164 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 165 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022-2025 (TON)
  • TABLE 166 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026-2031 (TON)
  • TABLE 167 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 168 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 169 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (TON)
  • TABLE 170 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (TON)
  • TABLE 171 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022-2025 (USD MILLION)
  • TABLE 172 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026-2031 (USD MILLION)
  • TABLE 173 REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 174 REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 175 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 176 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 177 REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 178 REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 179 REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 180 REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 181 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 182 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022-2025 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026-2031 (USD MILLION)
  • TABLE 185 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS, 2021-2026
  • TABLE 186 VITAMIN K2 MARKET: DEGREE OF COMPETITION
  • TABLE 187 VITAMIN K2 MARKET: REGION FOOTPRINT
  • TABLE 188 VITAMIN K2 MARKET: APPLICATION FOOTPRINT
  • TABLE 189 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 190 VITAMIN K2 MARKET: KEY DISTRIBUTORS/SUPPLIERS, 2025
  • TABLE 191 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
  • TABLE 192 VITAMIN K2 MARKET: PRODUCT LAUNCHES/DEVELOPMENTS, 2021-JUNE 2026
  • TABLE 193 VITAMIN K2 MARKET: DEALS, 2021-JUNE 2026
  • TABLE 194 VITAMIN K2 MARKET: EXPANSIONS, 2021-JUNE 2026
  • TABLE 195 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, 2021-JUNE 2026
  • TABLE 196 GNOSIS BY LESAFFRE: COMPANY OVERVIEW
  • TABLE 197 GNOSIS BY LESAFFRE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 198 GNOSIS BY LESAFFRE: PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 199 GNOSIS BY LESAFFRE: DEALS
  • TABLE 200 BALCHEM CORP.: COMPANY OVERVIEW
  • TABLE 201 BALCHEM CORP.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 202 BALCHEM CORP.: PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 203 BALCHEM CORP.: DEALS
  • TABLE 204 BALCHEM CORP.: EXPANSIONS
  • TABLE 205 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY OVERVIEW
  • TABLE 206 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
  • TABLE 207 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 208 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): DEALS
  • TABLE 209 NOVONESIS GROUP: COMPANY OVERVIEW
  • TABLE 210 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 211 NOVONESIS GROUP: DEALS
  • TABLE 212 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: COMPANY OVERVIEW
  • TABLE 213 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
  • TABLE 214 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: OTHER DEVELOPMENTS
  • TABLE 215 VESTA NUTRA: COMPANY OVERVIEW
  • TABLE 216 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 217 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 218 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 219 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 220 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
  • TABLE 221 MENADIONA: COMPANY OVERVIEW
  • TABLE 222 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 223 MENADIONA: PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 224 GF FERMENTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 225 GF FERMENTECH CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 226 GF FERMENTECH CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
  • TABLE 227 GF FERMENTECH CO., LTD.: DEALS
  • TABLE 228 ANGELYEAST CO., LTD.: COMPANY OVERVIEW
  • TABLE 229 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 230 ANGELYEAST CO., LTD.: EXPANSIONS
  • TABLE 231 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 232 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 233 GENEFERM BIOTECHNOLOGY CO., LTD.: EXPANSIONS
  • TABLE 234 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
  • TABLE 235 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 236 HAIHANG INDUSTRY CO., LTD.: COMPANY OVERVIEW
  • TABLE 237 HAIHANG INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 238 CHEMICEA LIMITED: COMPANY OVERVIEW
  • TABLE 239 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 240 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
  • TABLE 241 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 242 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
  • TABLE 243 MAGNESIA GMBH: COMPANY OVERVIEW
  • TABLE 244 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 245 ABCO INDIA: COMPANY OVERVIEW
  • TABLE 246 ATLANTIC CHEMICALS TRADING GMBH: COMPANY OVERVIEW
  • TABLE 247 MARKETS ADJACENT TO VITAMIN K2 MARKET
  • TABLE 248 DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 249 DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 250 VITAMINS MARKET, BY SOURCE, 2017-2022 (USD MILLION)
  • TABLE 251 VITAMINS MARKET, BY SOURCE, 2023-2028 (USD MILLION)

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 VITAMIN K2 MARKET, 2022-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VITAMIN K2, 2022-JUNE 2026
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF VITAMIN K2 MARKET
  • FIGURE 5 VITAMIN K2 MARKET: HIGH-GROWTH SEGMENTS, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 7 RISING DEMAND FOR PREVENTIVE HEALTHCARE AND NATURALLY FERMENTED VITAMIN K2 TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 8 CAPSULES & TABLETS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
  • FIGURE 9 NATURAL SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 10 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 11 MK7 SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 12 CAPSULES & TABLETS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 13 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 14 VITAMIN K2 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 HEALTH EXPENDITURE AS SHARE OF GDP FOR SELECTED COUNTRIES, 2014-2024
  • FIGURE 16 VITAMIN K2 MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2023-2030 (USD BILLION)
  • FIGURE 18 GLOBAL POPULATION GROWTH, 2000-2100 (BILLION)
  • FIGURE 19 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030
  • FIGURE 20 VITAMIN K2 MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 VITAMIN K2 MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TONS)
  • FIGURE 23 IMPORT OF HS CODE 293629, BY KEY COUNTRY, 2021-2025 (USD MILLION)
  • FIGURE 24 EXPORT OF HS CODE 293629, BY KEY COUNTRY, 2021-2025, (USD MILLION)
  • FIGURE 25 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
  • FIGURE 26 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 27 NUMBER OF PATENTS APPLIED AND GRANTED, 2016-2026
  • FIGURE 28 FUTURE APPLICATIONS
  • FIGURE 29 VITAMIN K2 MARKET DECISION-MAKING FACTORS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
  • FIGURE 31 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 33 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026 VS. 2031
  • FIGURE 34 VITAMIN K2 MARKET, BY SOURCE, 2026 VS. 2031
  • FIGURE 35 VITAMIN K2 MARKET, BY APPLICATION, 2026 VS. 2031
  • FIGURE 36 VITAMIN K2 MARKET, BY APPLICATION FORM, 2026 VS. 2031
  • FIGURE 37 ITALY TO RECORD HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 38 NORTH AMERICA: VITAMIN K2 MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: VITAMIN K2 MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY COMPANIES, 2023-2025 (USD BILLION)
  • FIGURE 41 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2025
  • FIGURE 42 COMPARATIVE ANALYSIS OF VENDOR BRANDS
  • FIGURE 43 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 44 VITAMIN K2 MARKET: COMPANY FOOTPRINT
  • FIGURE 45 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (DISTRIBUTORS/SUPPLIERS), 2025
  • FIGURE 46 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS
  • FIGURE 47 EV/EBITDA OF KEY COMPANIES
  • FIGURE 48 BALCHEM CORP.: COMPANY SNAPSHOT
  • FIGURE 49 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY SNAPSHOT
  • FIGURE 50 NOVONESIS GROUP: COMPANY SNAPSHOT
  • FIGURE 51 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 52 VITAMIN K2 MARKET: RESEARCH DESIGN
  • FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 54 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 55 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
  • FIGURE 56 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 57 DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!